CD274 and neoplasm: No significant differences were observed between the tumor immune microenvironments in patients of higher and lower risk groups, whether by measuring the infiltration of activated CD8+ T-cells (Fig. 3d), the level of PD-L1 mRNA expression (Fig. 3e), or the cytolytic activity (Fig. 3f).